This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Dr. Michel Vandenplas, Senior Scientist At Ross University School Of Veterinary Medicine (Photo: Business Wire)

Stocks in this article: DV

Michel Vandenplas, PhD, an accomplished biologist and equine medicine specialist, has joined Ross University School of Veterinary Medicine (RUSVM) as a senior scientist in the research department. He assumes overall responsibility for establishing an enhanced research facility to support high-quality and impactful research activities at RUSVM.

Dr. Michel Vandenplas, senior scientist at Ross University School of Veterinary Medicine (Photo: Bus ...

Dr. Michel Vandenplas, senior scientist at Ross University School of Veterinary Medicine (Photo: Business Wire)

“I share the vision of our Dean, faculty, staff and students to increase research efforts at our university focusing on tropical veterinary medicine and zoonosis. I will contribute to this vision through discussions with my fellow researchers and students interested in investigating veterinary research as a potential career path,” said Vandenplas. “Together we will form a team focused on strengthening our research program, an essential requirement for our current and future graduates.”

Vandenplas comes to RUSVM from the University of Georgia’s College of Veterinary Medicine, where he led research efforts focused on the role and regulation of innate immune responses in equine colic and lameness, the leading causes of morbidity and mortality in horses. He served as a molecular and cellular biology technical advisor to clinician researchers in the Departments of Large and Small Animal Medicine.

In addition to overseeing the operations of the research facilities, Vandenplas will continue his work with equine-specific innate immune responses, as compared to those of humans and other animals. His research interests also include developing a rapid and affordable whole-blood assessment of stress and using it to monitor the progression of disease and therapy in animals.

Vandenplas grew up near Cape Town, South Africa, and received his bachelor’s, master’s and doctoral degrees in medical biochemistry from the University of Stellenbosch in South Africa. He also worked with the South African Medical Research Council (MRC) Center for Molecular and Cellular Biology at the university, where he was involved in research to determine the role of gene mutations that alter the metabolism of the primary drug used to treat human tuberculosis.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs